Is There Enough Marijuana Research?

Listen to High Truths on Drugs and Addiction, Episode #3 with Dr. Ken Finn

Dr. Ken Finn, editor of the first medical textbook on Cannabis in Medicine and Vice President of the International Academy on Science and Impact of Cannabis (IASIC) joined Dr. Roneet Lev of the High Truths on Drugs and Addiction Episode #3 podcast for a discussion of marijuana research.

Is there enough marijuana research? We always hear the famous words “more research is needed.” While it is true that more research is always needed, always, until the end of time. Today, not tomorrow, we have enough research to disclose the serious health consequences of cannabis use.

Dr. Finn’s textbook includes 20 chapters, 554 pages, 72 authors and 2339 citations. Dr. Bertha Madras, diversion of neurochemistry at Harvard Medical School notes that there are over 15,000 manuscripts on marijuana topics.

Listen Now

About Dr. Ken Finn
Dr. Finn graduated medical school from the University of Texas Health Science Center-Houston (’90). He completed residency in Physical Medicine and Rehabilitation from the University of Utah (’94), and is board certified in Physical Medicine and Rehabilitation (’95) as well as Pain Medicine (’98), and Pain Management (’00). Practicing medicine in Colorado Springs since 1994, Finn serves on the American Board of Pain Medicine Exam Council (’01), Appeals Committee (’14), and Executive Board (’14). He is the President-Elect of the American Board of Pain Medicine (’20). Finn served on the Colorado Governors Task Force on Amendment 64, Consumer Safety and Social Issues Work Group (’12) and served 4 years on the Colorado Medical Marijuana Scientific Advisory Council (’14-’18). He was an Executive Board member of El Paso County Medical Society (’14-’18) and helped Colorado Medical Society and Colorado Pain Society develop their position statement on cannabis (’18) as well as the El Paso County Board of Health (’14) and Medical Society (’14) on their statements. Finn is a voluntary clinical instructor for the University of Colorado Medical School-Colorado Springs Branch (‘17-’20) and sees pain patients at the Colorado Springs Rehabilitation in Colorado.

Listen to Episode 3 Now

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on pinterest
Share on Pinterest

Leave a comment

Related Posts

What is THCP?

THCP, which is short for tetrahydrocannabiphorol and scientifically known as (-)-Trans-Δ9-tetrahydrocannabiphorol, is a natural cannabinoid and analog of THC present in varieties of cannabis. It’s thought to be 33 times more active at cannabinoid 1 (CB1) receptors than THC, causing an intense and intoxicating euphoric high. THCP’s legality is stuck between conflicting federal legislation. It’s not

Cannabis Legalization and Detection of Tetrahydrocannabinol (THC) in Injured Drivers

A recent study funded by the Canadian Institutes of Health Research found that after cannabis legalization, the prevalence of moderately injured drivers with a THC level of at least 2 ng per milliliter in participating British Columbia trauma centers more than doubled. The increase was largest among older drivers and male drivers. During the study

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol

For nearly a century, Cannabis has been stigmatized and criminalized across the globe, but in recent years, there has been a growing interest in Cannabis due to the therapeutic potential of phytocannabinoids. With this emerging interest in Cannabis, concerns have arisen about the possible contaminations of hemp with pesticides, heavy metals, microbial pathogens, and carcinogenic compounds during the cultivation, manufacturing,

Scroll to Top